Fast Five Quiz: Blastic Plasmacytoid Dendritic Cell Neoplasm Presentation and Diagnosis

Emmanuel C. Besa, MD


February 23, 2021

BPDCN offers a broad differential diagnosis in the skin. For this reason, it is important to order a variety of stains to confirm diagnosis. In addition to the CD123, CD4, CD56 triad of markers, TCL-1 is the other definitive marker for BPDCN. CD34 positivity indicates angiosarcoma and other sarcomas, while MPO positivity suggests AML. EBER positivity is associated with KN/t-cell lymphomas.

Learn more about the immunophenotypic features of BPDCN.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.